Today: 20 June 2026

GRAIL (GRAL) Stock Skyrockets on Samsung’s $110M Bet and Cancer-Screening Breakthrough

GRAIL (GRAL) Stock Skyrockets on Samsung’s $110M Bet and Cancer-Screening Breakthrough

GRAIL shares surged 13–14% to a record $85.35 on Oct. 16 after announcing a $110 million equity deal with Samsung and plans to bring its Galleri cancer test to Asia. New trial data at ESMO showed Galleri doubled early cancer detection versus routine screening. Despite gains, most analysts rate GRAL a “Hold” with an average target below current prices. Q2 revenue rose 11% to $35.5M; net loss narrowed to $114M.
18 October 2025
···
Bitfarms Stock Skyrockets 148% YTD on Bitcoin Boom and AI Pivot – Latest News & Outlook

Bitcoin Boom Sends Bitfarms (BITF) Stock Soaring – New $500M Deal & AI Pivot Fuel Rally

Bitfarms Ltd. (NASDAQ: BITF) closed at $5.01 on Friday, October 17, 2025, capping a volatile week that saw shares surge 19%, leading financial sector gains. The company announced a new CFO, secured $500 million in financing, and accelerated AI data center expansion. Bitcoin hit a record $125,000, boosting mining stocks. Bitfarms’ stock is up 148% year-to-date, with market cap near $2.8 billion.
18 October 2025
····
Disney Stock Could Soar? Analysts Pin 20% Upside on Streaming Shake-Up and Park Growth

Disney Stock Could Soar? Analysts Pin 20% Upside on Streaming Shake-Up and Park Growth

Disney shares closed at $110.70 on Oct. 17, up 1.4% for the week and nearly flat year-to-date. In August, Disney beat Q3 earnings estimates and raised full-year guidance, with parks income up 13% and streaming turning profitable. Disney+ and Hulu prices rise Oct. 21 as the company pushes a global Hulu rebrand and prepares a bundled “super app” for 2026. Wall Street rates DIS a “Moderate Buy” with a $133 average target.
18 October 2025
·
White House’s Shocking 10% Intel Stake Plan Shakes the Tech World

Intel Stock Soars to Multi-Year High on AI Buzz and Big Backers – Will the Rally Last?

Intel shares closed near $37 on Oct. 17, 2025, their highest in over two years, after Nvidia took a $5 billion stake and the U.S. government acquired about 10% of the company. Q2 revenue was flat at $12.9 billion, with Intel still unprofitable and CEO Lip-Bu Tan cutting 20% of staff. AMD and Nvidia continue to outpace Intel in the AI chip market. Q3 results are due Oct. 23.
18 October 2025
··
Apple Stock Could Explode After New AI Chip Launch and iPhone 17 “Supercycle,” Analysts Say

Apple Stock Could Explode After New AI Chip Launch and iPhone 17 “Supercycle,” Analysts Say

Apple closed at $252.29 on Oct. 17, 2025, just below its all-time intraday high near $260. Year-to-date, AAPL is up about 2%, trailing Nvidia and Microsoft. iPhone 17 sales are running 10–15% ahead of last year, and new M5-chip devices launched mid-October. COO Jeff Williams will retire by year-end, with John Ternus positioned as Tim Cook’s likely successor.
18 October 2025
···
Quantum Stocks (IonQ, Rigetti, D-Wave, Quantum Computing Inc) Surge 700–6,000% – Bubble or Breakthrough? (Oct. 13, 2025)

Rigetti’s Quantum Stock Rollercoaster: RGTI Soars 5,000% Amid Quantum Computing Hype, Then Stumbles – What’s Next?

Rigetti Computing shares hit a record $56.34 on Oct. 15 after surging 25% in a single day, then fell nearly 15% by Thursday and settled in the mid-$40s. The stock is up over 5,000% year-over-year, fueled by recent quantum computing contracts and product launches. Despite a $17 billion market cap, annual revenue remains around $8–10 million. All analysts rate the stock a “Buy” but set price targets far below current levels.
18 October 2025
··
GE Aerospace Stock Rockets as Rally Continues – Q3 Earnings, Contracts, and Analyst Targets in Focus

GE Aerospace Stock Rockets as Rally Continues – Q3 Earnings, Contracts, and Analyst Targets in Focus

GE Aerospace (NYSE: GE) closed at $300.14 on Oct 17, up 78% year-to-date, near its 52-week high of $307.25. Q3 earnings are due Oct 21, with analysts expecting $1.45 EPS on $10.3 billion sales, up 27% from last year. CEO Larry Culp’s contract was extended through 2027, and GE recently secured a $5 billion USAF F110 engine order. The quarterly dividend stands at $0.36 per share.
18 October 2025
··
Ford Stock Plunges as Devastating Supplier Fire and Recalls Turn 2025 Into a Nightmare

Ford Stock Rattled by Factory Fire and EV Slowdown – What Happens Next?

Ford shares closed at $11.92 Friday, recovering slightly after a 7% plunge on Oct. 7 following a fire at a key aluminum supplier’s plant that threatens F-150 production. Analysts estimate the blaze could cost Ford up to $1 billion in 2025 earnings. The company faces record recalls this year, regulatory penalties, and deepening losses in its EV division. U.S. EV sales for Ford fell 31% in Q2, prompting job cuts and delayed production targets.
18 October 2025
··
IBM Stock Rockets 28%: AI Boom, Quantum Breakthroughs & Big Deals Spark Rally

IBM Stock Rockets 28%: AI Boom, Quantum Breakthroughs & Big Deals Spark Rally

IBM closed at $281.28 on Oct. 17, up 28% year-to-date and near multi-year highs. The company announced new AI partnerships with Bharti Airtel, AMD, and Anthropic, and agreed to acquire SAP consultant Cognitus. IBM will report Q3 results on Oct. 22; analysts expect EPS around $3.00 and see limited upside unless AI/cloud growth accelerates. The stock yields 2.3% with a 45x P/E ratio.
18 October 2025
···
BigBear.ai (BBAI) Stock Rockets 80% in 2025 – Is the Defense-AI Rally Just Beginning?

BigBear.ai’s Stock Skyrockets on Defense AI Deals – Is BBAI the Next Palantir? 🚀

BigBear.ai shares jumped 22% on Oct. 13 after announcing a military AI partnership, reaching $9 before closing at $7.42 on Oct. 17. The company secured new U.S. defense contracts but reported Q2 revenue down 18% to $32.5 million and a net loss of $228.6 million. Wall Street rates the stock Hold, with a $6 average target. BigBear ended Q2 with $390 million in cash and a $380 million backlog.
18 October 2025
···
Psychedelic Biotech Rally: Atai Life Sciences Stock Soars 18% on FDA Breakthrough and $130M Fundraise

Psychedelic Biotech Rally: Atai Life Sciences Stock Soars 18% on FDA Breakthrough and $130M Fundraise

Atai Life Sciences shares surged 18% to close near $6.45 on Oct. 17, 2025, after the FDA granted Breakthrough Therapy status to its experimental depression nasal spray BPL-003. The company raised $130 million in a public offering at $5.48 per share. Analysts issued strong Buy ratings with targets up to $15. ARK Invest disclosed buying about 250,000 shares.
18 October 2025
·
Cisco Stock Surges Near 52-Week High on AI Momentum – What’s Next for CSCO?

Cisco Stock Surges Near 52-Week High on AI Momentum – What’s Next for CSCO?

Cisco Systems shares traded near $69–$70 on Oct. 17, 2025, close to a 52-week high and up about 30% over 12 months. The company reported Q4 earnings of $0.99 per share on $14.67 billion revenue, beating forecasts, and guided for 5–6% revenue growth in FY2026. Cisco launched new AI-focused products in October, with early orders from Microsoft and Alibaba. Market cap stands at roughly $270 billion.
18 October 2025
···
New Era Energy (NUAI) Stock Skyrockets on AI Data Center Pivot – Can the Rally Last?

New Era Energy (NUAI) Stock Skyrockets on AI Data Center Pivot – Can the Rally Last?

New Era Energy & Digital (NASDAQ: NUAI) closed at $4.55 on Oct. 17, up 44% for the day and 186% in two weeks, after announcing progress on its Texas AI data center project. The company regained Nasdaq compliance, ended plans for a new share sale, and now claims to be sufficiently funded. Market cap stands near $129 million. New Era remains pre-revenue, with heavy trading volume and ongoing volatility.
18 October 2025
···
MindMed Stock Rockets on Breakthrough LSD Anxiety Data – Analysts Eye 100% Upside

MindMed Stock Rockets on Breakthrough LSD Anxiety Data – Analysts Eye 100% Upside

MindMed shares hit a 52-week high of $13.09 on Oct. 14, up 68% year-to-date, after its LSD-derived drug MM120 showed 48% remission in a Phase 2b anxiety trial and received FDA Breakthrough Therapy status. The company holds $237.9 million in cash and is running three Phase 3 studies, with topline results due in 2026. Most analysts rate MNMD a “Moderate Buy” with an average 12-month target near $28.
18 October 2025
·
Virgin Galactic (SPCE) Stock Rockets 40% Then Reverses – What’s Fueling the Space Tourism Frenzy?

Virgin Galactic (SPCE) Stock Rockets 40% Then Reverses – What’s Fueling the Space Tourism Frenzy?

Virgin Galactic shares fell 7.9% to $4.08 on Oct. 18 after spiking over 40% earlier in the month, driven by heavy trading and high short interest. Q2 2025 revenue dropped to $0.4 million, with a net loss of $67 million. The company holds $508 million in cash, targeting late 2026 for its new Delta Class spaceplane’s first flight. Wall Street consensus is Neutral, with price targets recently cut to $2–$2.50 by some analysts.
18 October 2025
··
Sellas Life Sciences (SLS) Stock Rallies on Promising Leukemia Data – Analysts Eye Triple-Digit Upside

Sellas Life Sciences (SLS) Stock Rallies on Promising Leukemia Data – Analysts Eye Triple-Digit Upside

Sellas Life Sciences (NASDAQ:SLS) closed near $2.14 on Oct. 17, up about 100% year-to-date, with trading volatility and a 761% surge in call options on Oct. 14. Its GPS immunotherapy remains in Phase 3, while SLS009 showed strong preclinical results and a 44% response rate in Phase 2 AML data. Sellas raised $23.6M in September and had $25.3M cash at June 30. Analyst targets range from $6–7, with short interest at 18%.
18 October 2025
··
Rani Therapeutics (RANI) Stock Surges 150% on $1B+ Chugai Collaboration – Analysts Weigh In

Rani Therapeutics (RANI) Stock Surges 150% on $1B+ Chugai Collaboration – Analysts Weigh In

Rani Therapeutics shares surged over 150% on Oct. 17, 2025, after announcing a collaboration and license deal with Chugai Pharmaceutical worth up to $1.085 billion. The company also raised $60.3 million in PIPE financing, stating it now has funding into 2028. Trading volume spiked to 70 million shares, up from a 300,000 average. Analyst opinions remain split on the stock’s outlook.
18 October 2025
···
Beyond Meat Stock Implodes: 60% Crash After Shocking Debt-For-Equity Swap

Beyond Meat Stock Implodes: 60% Crash After Shocking Debt-For-Equity Swap

Beyond Meat shares plunged nearly 60% intraday on Oct. 13, 2025, closing at about $0.67 by Oct. 15—near record lows. The company swapped 96.9% of its 2027 convertible debt for $208.7 million in new notes and 316.15 million new shares, heavily diluting equity. Founder/CEO Ethan Brown and CFO Nandita Bakhshi resigned from the board. Analyst ratings remain strongly negative, with short interest at record highs.
18 October 2025
·
1 … 1,889 1,890 1,891 1,892 1,893 … 2,088

Stock Market Today

  • SGX Stock Review: Business Model and Earnings Outlook
    June 20, 2026, 5:47 PM EDT. Singapore Exchange (SGX) anchors Singapore's capital markets as the main listing and trading venue for equities and a growing derivatives hub. The exchange's revenue streams have diversified from traditional equities to include derivatives and data services, offering more stable and recurring income. Derivatives such as equity index futures and commodities now form a significant revenue component. SGX's stable earnings and dividend policy reflect its asset-light, cash-generative business model. The company is strategically expanding its multi-asset, pan-Asian platform with FX futures, OTC clearing, and cross-border listings to capture regional risk-management demand and broaden its investor base.

Latest articles

Go toTop